Michael G. White, M.D., MSc

Peer-Reviewed Articles

1. Yousef A, Yousef M, Zeineddine M, More A, Fanaeian M, Chowdhury S, Knafl M, Edelkamp P, Ito I, Gu Y, Pattalachinti V, Naini ZA, Zeineddine F, Peterson J, Alfaro K, Foo WC, Jin J, Bhutiani N, Higbie V, Scally C, Kee B, Kopetz S, Goldstein D, Strach M, Wiliamson A, Aziz O, Barriuso J, Uppal A, White MG, Helmink B, Fournier K, Raghav K, Taggart M, Overman MJ, Shen JP. Serum Tumor Markers and Outcomes in Patients with Appendiceal Adenocarcinoma. JAMA Netw Open 7(2), 2024. PMID: 38416491.
2. Liu, Q, Adhikari, E, Lester, DK, Fang, B, Johnson, JO, Tian, Y, Mockabee-Macias, A, Izumi, V, Guzman, KM, White, MG, Koomen, JM, Wargo, J, Messina, JL, Qi, J, Lau, E. Androgen drives melanoma invasiveness and metastatic spread by inducing tumorigenic fucosylation. Nature communications 15(1), 2024. PMID: 38326303.
3. Liu Q, Adhikari E, Lester D, Fang B, Johnson J, Tian Y, Mockabee-Macias A, Izumi V, Guzman K, White MG, Koomen J, Wargo J, Messina J, Qi J. Androgen Drives Melanoma Invasiveness and Metastatic Spread by inducing Tumorigenic Fucosylation. Nat Commun 15(1):1148, 2024. PMID: None.
4. Bhutiani, N, Grotz, TE, Concors, SJ, White, MG, Helmink, BA, Raghav, KS, Taggart, MW, Beaty, K, Royal, RE, Overman, MJ, Matamoros Jr, A, Scally, CP, Rafeeq, S, Mansfield, PF, Fournier, KF. Repeat Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Appendiceal Adenocarcinoma. Annals of surgical oncology 31(1):614-621, 2024. PMID: 37872456.
5. Bhutiani N, Peacock O, Uppal A, You YN, Bednarski B, Skibber J, White MG, Chang G, Konishi T. The Current Multidisciplinary Management of Rectal Cancer. Ann GI Surg. e-Pub 2024. PMID: None.
6. Ito I, Yousef AMG, Chowdhury S, Dickson PN, Naini ZA, White MG, Fleten KG, Flatmark K, Fournier KF, Fowlkes NW, Shen JP. Intraperitoneal paclitaxel is a safe and effective therapeutic strategy for treating mucinous appendiceal adenocarcinoma. Cancer Res 83(19):3184-3191, 2023. e-Pub 2023. PMID: 37433032.
7. White MG, Damania A, Alshenaifi J, Sahasrabhojane P, Peacock O, Losh J, Wong MC, Lutter-Berkova Z, Chang GJ, Futreal A, Wargo JA, Ajami NJ, Kopetz S, You YN. Young-onset Rectal Cancer: Unique Tumoral Microbiome and Correlation with Response to Neoadjuvant Therapy. Ann Surg 278(4):538-548, 2023. e-Pub 2023. PMID: 37465976.
8. Wang J, Rozycki MT, Tong X, White MG. Aggregation of Size-Selected Oxide Clusters Deposited onto Au(111). Langmuir 39(38):13481-13492, 2023. e-Pub 2023. PMID: 37695694.
9. Yousef A, Yousef M, Zeineddine M, More A, Chowdhury S, Knafl M, Edelkamp P, Ito I, Gu Y, Pattalachinti V, Naini ZA, Zeineddine F, Peterson J, Alfaro K, Foo WC, Jin J, Bhutiani N, Higbie V, Scally C, Kee B, Kopetz S, Goldstein D, Uppal A, White MG, Helmink B, Fournier K, Raghav K, Taggart M, Overman MJ, Shen JP. The Clinical Significance of CEA, CA19-9, and CA125 in Management of Appendiceal Adenocarcinoma. medRxiv, 2023. e-Pub 2023. PMID: 37745596.
10. White MG, Bhutiani N, Helmink BA, Taggart M, Foo WC, Mansfield PF, Fournier KF, Scally CP. Treatment Variation and Long-Term Outcomes of Low-Grade Appendiceal Neoplasms. Ann Surg Oncol. e-Pub 2023. PMID: 37702905.
11. Bhutiani N, Helmink BA, Zeineddine M, Uppal A, Shen JP, Spickard E, White MG. Utility of Circulating Tumor DNA in Appendiceal Tumors. J Gastrointest Surg. e-Pub 2023. PMID: 37709990.
12. Bhutiani N, White MG, Kim BJ, Scally CP, Helmink BA, Mansfield PF, Fournier KF, Royal RE. Decreasing Environmental Operating Room Chemotherapy Levels Following Heated Intraperitoneal Chemotherapy (HIPEC) Through Implementation of Standard Protocols. Ann Surg Oncol. e-Pub 2023. PMID: 37624514.
13. Bhutiani N, White M, Kim BJ, Robinson KA, Cox D, Ivey S, Scally CP, Helmink BA, Mansfield PM, Fournier KF, Royal R. Environmental Operating Room Chemotherapy Levels Following Heated Intraperitoneal Chemotherapy (HIPEC). Ann Surg Onc. e-Pub 2023. PMID: 37624514.
14. Leo J, Dondossola E, Basham KJ, Wilson NR, Alhalabi O, Gao J, Kurnit KC, White M, McQuade JL, Westin SN, Wellberg EA, Frigo DE. Stranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate Cancer. Endocrinology, 2023. PMID: 37154098.
15. Blumenthaler AN, Robinson KA, Hodge C, Xiao L, Lilley EJ, Griffin JF, White MG, Day R, Tanco K, Bruera E, Badgwell BD. Communication Frameworks for Palliative Surgical Consultations: A Randomized Study of Advanced Cancer Patients. Ann Surg, 2023. e-Pub 2023. PMID: 36806227.
16. Lester DK, Burton C, Gardner A, Innamarato P, Kodumudi K, Liu Q, Adhikari E, Ming Q, Williamson DB, Frederick DT, Sharova T, White MG, Markowitz J, Cao B, Nguyen J, Johnson J, Beatty M, Mockabee-Macias A, Mercurio M, Watson G, Chen PL, McCarthy S, MoranSegura C, Messina J, Thomas KL, Darville L, Izumi V, Koomen JM, Pilon-Thomas SA, Ruffell B, Luca VC, Haltiwanger RS, Wang X, Wargo JA, Boland GM, Lau EK. Fucosylation of HLA-DRB1 regulates CD4+ T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy. Nat Cancer, 2023. e-Pub 2023. PMID: 36690875.
17. Cass S, White M. The Influence of the Microbiome on Metastatic Colorectal Cancer. Clin Colon Rectal Surg. e-Pub 2023. PMID: 36844707.
18. White MG, Vellano CP, Andrews MC, Chelvanambi M, Witt RG, Daniele JR, Titus M, McQuade JL, Conforti F, Burton EM, Lastrapes MJ, Ologun G, Cogdill AP, Morad G, Prieto P, Lazar AJ, Chu Y, Han G, Khan MAW, Helmink B, Davies MA, Amaria RN, Kovacs JJ, Woodman SE, Patel S, Hwu P, Peoples M, Lee JE, Cooper ZA, Zhu H, Gao G, Banerjee H, Lau M, Gershenwald JE, Lucci A, Keung EZ, Ross MI, Pala L, Pagan E, Segura RL, Liu Q, Borthwick MS, Lau E, Yates MS, Westin SN, Wani K, Tetzlaff MT, Haydu LE, Mahendra M, Ma X, Logothetis C, Kulstad Z, Johnson S, Hudgens CW, Feng N, Federico L, Long GV, Futreal PA, Arur S, Tawbi HA, Moran AE, Wang L, Heffernan TP, Marszalek JR, Wargo JA. Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy. Nature 606(7915):797-803, 2022. e-Pub 2022. PMID: 35705814.
19. Bhutiani N, Cox DM, Robinson KA, Kim BJ, Mansfield PF, Fournier KF, White MG. Stapled Versus Hand-Sewn Anastomosis in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy. J Gastrointest Surg. e-Pub 2022. PMID: 35676459.
20. Cass SH, Ajami NJ, White MG. Correction to: The Microbiome: the Link to Colorectal Cancer and Research Opportunities. Curr Treat Options Oncol 23(5):774, 2022. PMID: 35380339.
21. Kothari A, White MG, Peacock O, Kaur H, Palmquist SM, You N, Taggart M, Salem U, Overman M, Kopetz S, Chang GJ. Pathological response following neoadjuvant immunotherapy in mismatch repair-deficient/microsatellite instability-high locally advanced, non-metastatic colorectal cancer. Br J Surg 109(6):489-492, 2022. PMID: 35576377.
22. Pourmaleki M, Jones CJ, Ariyan CE, Zeng Z, Pirun M, Navarrete DA, Li Y, Zhang M, Nandakumar S, Campos C, Nadeem S, Klimstra DS, Temple-Oberle CF, Brenn T, Lipson EJ, Schenk KM, Stein JE, Taube JM, White MG, Traweek R, Wargo JA, Kirkwood JM, Gasmi B, Goff SL, Corwin AD, McDonough E, Ginty F, Callahan MK, Schietinger A, Socci ND, Mellinghoff IK, Hollmann TJ. Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma. Cancer Immunol Res 10(3):303-313, 2022. PMID: 35013003.
23. White MG, Badgwell B. Oncologic Components of HIPEC: Key Question : In patients with gastric or colorectal adenocarcinoma metastatic to the peritoneum, does cytoreductive surgery (CRS) plus hyperthermic intraperitoneal perfusion with chemotherapy (HIPEC) prolong survival or increase the risk of complications relative to CRS alone?. Ann Surg Oncol. e-Pub 2022. PMID: 34994900.
24. Spencer CN, McQuade JL, Gopalakrishnan V, McCulloch JA, Vetizou M, Cogdill AP, Khan MAW, Zhang X, White MG, Peterson CB, Wong MC, Morad G, Rodgers T, Badger JH, Helmink BA, Andrews MC, Rodrigues RR, Morgun A, Kim YS, Roszik J, Hoffman KL, Zheng J, Zhou Y, Medik YB, Kahn LM, Johnson S, Hudgens CW, Wani K, Gaudreau PO, Harris AL, Jamal MA, Baruch EN, Perez-Guijarro E, Day CP, Merlino G, Pazdrak B, Lochmann BS, Szczepaniak-Sloane RA, Arora R, Anderson J, Zobniw CM, Posada E, Sirmans E, Simon J, Haydu LE, Burton EM, Wang L, Dang M, Clise-Dwyer K, Schneider S, Chapman T, Anang NAS, Duncan S, Toker J, Malke JC, Glitza IC, Amaria RN, Tawbi HA, Diab A, Wong MK, Patel SP, Woodman SE, Davies MA, Ross MI, Gershenwald JE, Lee JE, Hwu P, Jensen V, Samuels Y, Straussman R, Ajami NJ, Nelson KC, Nezi L, Petrosino JF, Futreal PA, Lazar AJ, Hu J, Jenq RR, Tetzlaff MT, Yan Y, Garrett WS, Huttenhower C, Sharma P, Watowich SS, Allison JP, Cohen L, Trinchieri G, Daniel CR, Wargo JA. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science 374(6575):1632-1640, 2021. e-Pub 2021. PMID: 34941392.
25. Zhang LM, Schuitevoerder D, White MG, Feldt S, Krishnan P, Hyman N, Shogan BD. Combined mechanical and oral antibiotic bowel preparation is associated with prolonged recurrence-free survival following surgery for colorectal cancer. J Surg Oncol 124(7):1106-1114, 2021. e-Pub 2021. PMID: 34310702.
26. Applewhite M, White MG, Kaplan E, Angelos P, Grogan R. Failure to Intervene on Thyroid Cancer. World J End Surg 13(2):10002-1405, 2021. PMID: None.
27. White MG, Badgwell BD. Laparoscopic Heated Intraperitoneal Chemotherapy in the Treatment of Carcinomatosis of Gastric Adenocarcinoma Origin. J Clin Med 10(20), 2021. e-Pub 2021. PMID: 34682880.
28. Newton AD, Newhook TE, Ikoma N, White MG, Tzeng CD, Chun YS, Aloia TA, Vauthey JN, Tran Cao HS. Robotic Completion Radical Cholecystectomy with Fluorescence Guidance. Ann Surg Oncol 28(11):6834, 2021. e-Pub 2021. PMID: 33774771.
29. Sloane RAS, White MG, Witt RG, Banerjee A, Davies MA, Han G, Burton E, Ajami N, Simon JM, Bernatchez C, Haydu LE, Tawbi HA, Gershenwald JE, Keung E, Ross M, McQuade J, Amaria RN, Wani K, Lazar AJ, Woodman SE, Wang L, Andrews MC, Wargo JA. Identification of MicroRNA-mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes. Cancers (Basel) 13(21), 2021. e-Pub 2021. PMID: 34771465.
30. Andrews MC, Duong CPM, Gopalakrishnan V, Iebba V, Chen WS, Derosa L, Khan MAW, Cogdill AP, White MG, Wong MC, Ferrere G, Fluckiger A, Roberti MP, Opolon P, Alou MT, Yonekura S, Roh W, Spencer CN, Curbelo IF, Vence L, Reuben A, Johnson S, Arora R, Morad G, Lastrapes M, Baruch EN, Little L, Gumbs C, Cooper ZA, Prieto PA, Wani K, Lazar AJ, Tetzlaff MT, Hudgens CW, Callahan MK, Adamow M, Postow MA, Ariyan CE, Gaudreau PO, Nezi L, Raoult D, Mihalcioiu C, Elkrief A, Pezo RC, Haydu LE, Simon JM, Tawbi HA, McQuade J, Hwu P, Hwu WJ, Amaria RN, Burton EM, Woodman SE, Watowich S, Diab A, Patel SP, Glitza IC, Wong MK, Zhao L, Zhang J, Ajami NJ, Petrosino J, Jenq RR, Davies MA, Gershenwald JE, Futreal PA, Sharma P, Allison JP, Routy B, Zitvogel L, Wargo JA. Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade. Nat Med 27(8):1432-1441, 2021. e-Pub 2021. PMID: 34239137.
31. White MG, Lee A, Vicente D, Hall C, Kim MP, Katz MHG, Lee JE, Ikoma N, Lucci A, Tzeng CD. Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol 28(8):4615-4622, 2021. e-Pub 2021. PMID: 33415562.
32. White MG, Eng OS. Response to Comment on "Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy". Br J Cancer 124(6):1179-1180, 2021. e-Pub 2020. PMID: 33318658.
33. White MG, Tzeng CW, Ikoma N, Chun YS, Aloia TA, Vauthey JN, Cao HST. Robotic Partial Segment VIII Resection. Ann Surg Oncol 28(3):1513, 2021. e-Pub 2020. PMID: 32761429.
34. White MG, Schulte JJ, Xue L, Berger Y, Schuitevoerder D, Vining CC, Kindler HL, Husain A, Turaga KK, Eng OS. Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy. Br J Cancer 124(3):564-566, 2021. e-Pub 2020. PMID: 33100328.
35. White MG, Szczepaniak Sloane R, Witt RG, Reuben A, Gaudreau PO, Andrews MC, Feng N, Johnson S, Class CA, Bristow C, Wani K, Hudgens C, Nezi L, Manzo T, De Macedo MP, Hu J, Davis R, Jiang H, Prieto P, Burton E, Hwu P, Tawbi H, Gershenwald J, Lazar AJ, Tetzlaff MT, Overwijk W, Woodman SE, Cooper ZA, Marszalek JR, Davies MA, Heffernan TP, Wargo JA. Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in Braf-mutated melanoma. Oncoimmunology 10(1):1992880, 2021. e-Pub 2021. PMID: 34777916.
36. White MG, Tran Cao HS. ASO Author Reflections: The Role of the Robot in Liver Surgery: An Evolution in Progress. Ann Surg Oncol 27(Suppl 3):897-898, 2020. e-Pub 2020. PMID: 32813200.
37. White MG, Kothari A, Ikoma N, Murphy MB, Song S, Ajani J, Mansfield P, Badgwell B. Factors Associated with Resection and Survival After Laparoscopic HIPEC for Peritoneal Gastric Cancer Metastasis. Ann Surg Oncol 27(13):4963-4969, 2020. e-Pub 2020. PMID: 32648181.
38. White MG, Wargo JA. Gut Microbes' Impact on Oncogenic Drivers: Location Matters. Mol Cell 79(6):878-880, 2020. PMID: 32946762.
39. Working Group CC. The Chicago Consensus on peritoneal surface malignancies: Management of desmoplastic small round cell tumor, breast, and gastrointestinal stromal tumors. Cancer 126(11):2566-2570, 2020. e-Pub 2020. PMID: 32282072.
40. Working Group CC. The Chicago Consensus on peritoneal surface malignancies: Management of gastric metastases. Cancer 126(11):2541-2546, 2020. e-Pub 2020. PMID: 32282074.
41. Working Group CC. The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms. Cancer 126(11):2553-2560, 2020. e-Pub 2020. PMID: 32282068.
42. Working Group CC. The Chicago Consensus on peritoneal surface malignancies: Standards. Cancer 126(11):2516-2524, 2020. e-Pub 2020. PMID: 32282066.
43. Working Group CC. The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma. Cancer 126(11):2547-2552, 2020. e-Pub 2020. PMID: 32282077.
44. Working Group CC. The Chicago Consensus on peritoneal surface malignancies: Management of neuroendocrine tumors. Cancer 126(11):2561-2565, 2020. e-Pub 2020. PMID: 32282069.
45. Working Group CC. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Neuroendocrine Tumors. Ann Surg Oncol 27(6):1788-1792, 2020. e-Pub 2020. PMID: 32285274.
46. Working Group CC. The Chicago Consensus on peritoneal surface malignancies: Management of colorectal metastases. Cancer 126(11):2534-2540, 2020. e-Pub 2020. PMID: 32282070.
47. Working Group CC. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumors. Ann Surg Oncol 27(6):1793-1797, 2020. e-Pub 2020. PMID: 32285268.
48. Working Group CC. The Chicago Consensus on peritoneal surface malignancies: Palliative care considerations. Cancer 126(11):2571-2576, 2020. e-Pub 2020. PMID: 32282059.
49. Working Group CC. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms. Ann Surg Oncol 27(6):1780-1787, 2020. e-Pub 2020. PMID: 32285271.
50. Working Group CC. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Gastric Metastases. Ann Surg Oncol 27(6):1768-1773, 2020. e-Pub 2020. PMID: 32285269.
51. Working Group CC. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Peritoneal Mesothelioma. Ann Surg Oncol 27(6):1774-1779, 2020. e-Pub 2020. PMID: 32285273.
52. Working Group CC. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Colorectal Metastases. Ann Surg Oncol 27(6):1761-1767, 2020. e-Pub 2020. PMID: 32285270.
53. Working Group CC. The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations. Ann Surg Oncol 27(6):1798-1804, 2020. e-Pub 2020. PMID: 32285272.
54. Working Group CC. The Chicago Consensus on peritoneal surface malignancies: Management of appendiceal neoplasms. Cancer 126(11):2525-2533, 2020. e-Pub 2020. PMID: 32282073.
55. Working Group CC. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms. Ann Surg Oncol 27(6):1753-1760, 2020. e-Pub 2020. PMID: 32285275.
56. Ruhle BC, White MG, Alsafran S, Kaplan EL, Angelos P, Grogan RH. Keeping primary aldosteronism in mind: Deficiencies in screening at-risk hypertensives. Surgery 165(1):221-227, 2019. e-Pub 2018. PMID: 30415872.
57. Cipriani NA, White MG, Angelos P, Grogan RH. Large Cytologically Benign Thyroid Nodules Do Not Have High Rates of Malignancy or False-Negative Rates and Clinical Observation Should be Considered: A Meta-Analysis. Thyroid 28(12):1595-1608, 2018. e-Pub 2018. PMID: 30280990.
58. James BC, Aschebrook-Kilfoy B, White MG, Applewhite MK, Kaplan SP, Angelos P, Kaplan EL, Grogan RH. Quality of life in thyroid cancer-assessment of physician perceptions. J Surg Res 226:94-99, 2018. e-Pub 2018. PMID: 29661295.
59. White MG, Applewhite MK, Kaplan EL, Angelos P, Huo D, Grogan RH. A Tale of Two Cancers: Traveling to Treat Pancreatic and Thyroid Cancer. J Am Coll Surg 225(1):125-136.e6, 2017. e-Pub 2017. PMID: 28473189.
60. Cavallo A, Johnson DN, White MG, Siddiqui S, Antic T, Mathew M, Grogan RH, Angelos P, Kaplan EL, Cipriani NA. Thyroid Nodule Size at Ultrasound as a Predictor of Malignancy and Final Pathologic Size. Thyroid 27(5):641-650, 2017. e-Pub 2017. PMID: 28052718.
61. White MG, Ward MA, Applewhite MK, Wong H, Prachand V, Angelos P, Kaplan EL, Grogan RH. Rates of secondary hyperparathyroidism after bypass operation for super-morbid obesity: An overlooked phenomenon. Surgery 161(3):720-726, 2017. e-Pub 2016. PMID: 27769660.
62. Applewhite MK, White MG, Tseng J, Mohammed MK, Mercier F, Kaplan EL, Angelos P, Vokes T, Grogan RH. Normohormonal primary hyperparathyroidism is a distinct form of primary hyperparathyroidism. Surgery 161(1):62-69, 2017. e-Pub 2016. PMID: 27866715.
63. Applewhite MK, White MG, James BC, Abdulrasool L, Kaplan EL, Angelos P, Grogan RH. Ultrasonic, bipolar, and integrated energy devices: comparing heat spread in collateral tissues. J Surg Res 207:249-254, 2017. e-Pub 2016. PMID: 28341269.
64. Applewhite MK, White MG, Xiong M, Pasternak JD, Abdulrasool L, Ogawa L, Suh I, Gosnell JE, Kaplan EL, Duh QY, Angelos P, Shen WT, Grogan RH. Incidence, Risk Factors, and Clinical Outcomes of Incidental Parathyroidectomy During Thyroid Surgery. Ann Surg Oncol 23(13):4310-4315, 2016. e-Pub 2016. PMID: 27541813.
65. White MG, Millis M, Lo A. Handlebar Injury with Evisceration and Perforation of Roux-en-Y Anastomosis in a Liver Transplanted 7-Year-Old. J Ped Surg Case Reports:32-33, 2016. PMID: None.
66. White MG, Cipriani NA, Abdulrasool L, Kaplan S, Aschebrook-Kilfoy B, Angelos P, Kaplan EL, Grogan RH, Onel K. Radiation-Induced Differentiated Thyroid Cancer Is Associated with Improved Overall Survival but Not Thyroid Cancer-Specific Mortality or Disease-Free Survival. Thyroid 26(8):1053-60, 2016. PMID: 27279587.
67. White MG, Nagar S, Aschebrook-Kilfoy B, Jasmine F, Kibriya MG, Ahsan H, Angelos P, Kaplan EL, Grogan RH. Epigenetic Alterations and Canonical Pathway Disruption in Papillary Thyroid Cancer: A Genome-wide Methylation Analysis. Ann Surg Oncol 23(7):2302-9, 2016. e-Pub 2016. PMID: 26979305.
68. Siddiqui S, White MG, Antic T, Grogan RH, Angelos P, Kaplan EL, Cipriani NA. Clinical and Pathologic Predictors of Lymph Node Metastasis and Recurrence in Papillary Thyroid Microcarcinoma. Thyroid 26(6):807-15, 2016. e-Pub 2016. PMID: 27117842.
69. White MG, James BC, Nocon C, Nagar S, Kaplan EL, Angelos P, Grogan RH. One-hour PTH after thyroidectomy predicts symptomatic hypocalcemia. J Surg Res 201(2):473-479, 2016. e-Pub 2015. PMID: 27020834.
70. Cipriani NA, Nagar S, Kaplan SP, White MG, Antic T, Sadow PM, Aschebrook-Kilfoy B, Angelos P, Kaplan EL, Grogan RH. Follicular Thyroid Carcinoma: How Have Histologic Diagnoses Changed in the Last Half-Century and What Are the Prognostic Implications?. Thyroid 25(11):1209-16, 2015. e-Pub 2015. PMID: 26440366.
71. Uppal A, White MG, Nagar S, Aschebrook-Kilfoy B, Chang PJ, Angelos P, Kaplan EL, Grogan RH. Benign and Malignant Thyroid Incidentalomas Are Rare in Routine Clinical Practice: A Review of 97,908 Imaging Studies. Cancer Epidemiol Biomarkers Prev 24(9):1327-31, 2015. e-Pub 2015. PMID: 26160694.
72. Keegan TH, Grogan RH, Parsons HM, Tao L, White MG, Onel K, Horn-Ross PL. Sociodemographic disparities in differentiated thyroid cancer survival among adolescents and young adults in California. Thyroid 25(6):635-48, 2015. e-Pub 2015. PMID: 25778795.
73. Bhutiani N, Seo YD, Robinson KA, White MG, Ikoma N, Mansfield PF, Li JJ, Murphy MB, Ajani JA, Badgwell BD. HIPEC for Metastatic Gastric Cancer: Moving the Needle Towards 3-Year Survival. ESMO. PMID: None.
74. Belmont E, Bansal VV, Yousef MMG, Zeineddine MA, Su D, Dhiman A, Liao CY, Polite B, Eng OS, Fournier KR, White MG, Turagag KK, Shen JP, Shergill A. Multi-institutional study evaluating the role of circulating tumor DNA in the management of appendix cancer. JCO Precis Onc. PMID: None.
75. Bhutiani N, Grotz TE, Concors SJ, White MG, Helmink BA, Raghav KP, Taggart MW, Beaty KA, Royal RE, Overman MJ, Matamoros A, Scally CP, Rafeeq S, Mansfield PF, Fournier KF. Repeat Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Appendiceal Adenocarcinoma: A Viable Treatment Strategy with Demonstrable Benefit. Ann Surg Onc. PMID: None.
76. Ayabe R, White MG. Metastasis and the Microbiome: The Impact of Bacteria in Disseminated Colorectal Cancer. Frontiers in Bioscience-Landmark. PMID: None.

Invited Articles

1. White M, Bhutiani N, Helmink BA, Taggart M, Foo WC, Mansfield PF, Fournier KF, Scally CP. ASO Visual Abstract: Treatment Variation and Long-Term Outcomes of Low-Grade Appendiceal Neoplasms. Ann Surg Oncol. e-Pub 2023. PMID: 37728822.
2. White M, Scallly CP. ASO Author Reflections: Contemporary Management of Low-Grade Appendiceal Mucinous Neoplasms. Ann Surg Onc, 2023. PMID: 37231292.
3. White M, Badgwell B. ASO Visual Abstract: Oncologic Components of HIPEC: Key Question. Ann Surg Onc. e-Pub 2022. PMID: 35275326.
4. White M, Tzeng CD. ASO Author Reflections: Potential Role of Circulating Biomarkers in Resected Pancreatic Adenocarcinoma. Ann Surg Onc 28(8):4623-4624, 2021. PMID: 33507452.
5. White M, Tran Cao HS. ASO Author Reflections: The Role of the Robot in Liver Surgery – an Evolution in Progress. Ann Surg Onc 27(Suppl 3):897-898, 2020. PMID: 32813200.
6. White MG, Wargo J. Gut microbes’ impact on oncogenic drivers: location matters. Mol Cell 79(6):878-880, 2020. PMID: 32946762.
7. Grogan RH, White M, Angelos P. Thyroid Incidentalomas and the Overdiagnosis Conundrum. Int J End Onc 3(3), 2016. PMID: None.

Other Articles

1. Bhutiani, N, Peacock, O, Uppal, A, You, YN, Bednarski, BK, Skibber, JM, Messick, C, White, MG, Chang, GJ, Konishi, T The current multidisciplinary management of rectal cancer. Annals of Gastroenterological Surgery 8(3):394-400, 2024. PMID: 38707228.
2. Schokrpur, S, White, MG, Roland, CL, Patel, SP Immuno-Oncology. Surgical oncology clinics of North America 33(2):265-278, 2024. PMID: 38401909.
3. Yousef A, Yousef M, Zeineddine M, More A, Chowdhury S, Knafl M, Edelkamp P, Ito I, Gu Y, Pattalachinti V, Naini ZA, Zeineddine F, Peterson J, Alfaro K, Foo WC, Jin J, Bhutiani N, Higbie V, Scally S, Kee BK, Kopetz S, Goldstein D, Uppal A, White MG, Helmink B, Fournier K, Raghav KP, Taggart M, Overman M, Shen JP The Clinical Significance of CEA, CA19-9, and CA125 in Management of Appendiceal Adenocarcinoma. medRxiv, 2023. PMID: None.
4. Liu Q, Adhikari E, Lester D, Fang B, Johnson J, Tian Y, Mockabee-Macias A, Izumi V, Guzman K, White MG, Koomen J, Wargo J, Messina JL, Qi J, Lau E Androgen Drives Melanoma Invasiveness and Metastatic Capacity by Promoting Tumorigenic Fucosylation. Research Square, 2023. PMID: None.
5. Ito I, Yousef AM, Dickson PN, Naini ZA, White MG, Fournier KF, Fowlkes NW, Shen JP Antitumor activity of intraperitoneal paclitaxel in orthotopic patient-derived xenograft models of mucinous appendiceal adenocarcinoma. Cancer Research, 2023. PMID: None.
6. Ito I, Yousef MGA, Dickson PN, Naini ZA, White M, Fleten KG, Flatmark K, Fournier KF, Fowlkes NW, Shen JP Antitumor activity of intraperitoneal paclitaxel in orthotopic patient-derived xenograft models of mucinous appendiceal adenocarcinoma. bioRxiv, 2023. PMID: None.
7. White MG, Wargo JA The Microbiome in Gastrointestinal Cancers. Gastroenterol Clin North Am 51(3):667-680, 2022. PMID: 36153116.
8. Cass SH, Ajami NJ, White MG The Microbiome: the Link to Colorectal Cancer and Research Opportunities. Curr Treat Options Oncol 23(5):631-644, 2022. PMID: 35254596.
9. White MG, Morgan RB, Drazer MW, Eng OS Gastrointestinal Surgical Emergencies in the Neutropenic Immunocompromised Patient. J Gastrointest Surg 25(12):3258-3264, 2021. PMID: 34506017.
10. Parker KG, White MG, Cipriani NA Comparison of Molecular Methods and BRAF Immunohistochemistry (VE1 Clone) for the Detection of BRAF V600E Mutation in Papillary Thyroid Carcinoma: A Meta-Analysis. Head Neck Pathol 14(4):1067-1079, 2020. PMID: 32358715.
11. Nielsen SM, White MG, Hong S, Aschebrook-Kilfoy B, Kaplan EL, Angelos P, Kulkarni SA, Olopade OI, Grogan RH The Breast-Thyroid Cancer Link: A Systematic Review and Meta-analysis. Cancer Epidemiol Biomarkers Prev 25(2):231-8, 2016. PMID: 26908594.

Editorials

1. Uppal U, White MG, Shen JP, Chang G. Colorectal Peritoneal Metastases: We Must Translate Genomics to Multidisciplinary Clinical Care. ASCO Daily News, 2022. PMID: None.
2. White MG, Eng OS. Response to Comment on “Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy". BJC 124(6):1179-1180, 2021. PMID: 33318658.

Abstracts

1. Bhutiani N, Ochiachi K, Konishi T, Peacock O, Chang GJ, You YN, Bednarski B, Messick C, Skibber JM, White M, Uppal A. Risk Factors for Regrowth after Nonoperative Management for Rectal Cancer. Presidential Plenary Presentation. Digestive Diseases Week, Washington DC, 2024. PMID: None.
2. Chelvanambi M, Damania AV, Johnson SB, Morad G, Lazcano RN, Helmink BA, Fong LW, Wani K, Seo YD, Park EM, Ayabe R, Singh B, Wong MC, Ingram DR, White M, Lazar AJ, Mishra AK, Ajami NJ, Baruch EN, Wargo J. Engraftment as a determinant of response in fecal microbiome transplantation interventions for immunotherapy in melanoma. American Association of Cancer Researchers Annual Meeting. San Diego CA, 2024. PMID: None.
3. Chelvanambi M, Melendez B, Haddad EN, Lazcano RN, Lastrapes MJ, Bhusan BS, Johnson SB, Wani K, Ingram DR, Seo YD, Helmink BH, White M, Witt R, Diggs LP, Morad G, Zelazowska MA, Paul S, Dimitriou F, Damania AV, Wong MC, Somaiah N, Ajami NJ, Keung E, Fridman WH, Allison JP, Sharma P, McBride KM, Cascone T, Roland CL, Lazar AJ, Wargo J. Spatial profiling reveals unique immune-transcriptomic features of tertiary lymphoid structures in melanoma. American Association of Cancer Researchers Annual Meeting. San Diego CA, 2024. PMID: None.
4. Fallon E, Awiwi MO, Bhutiani N, Helmink B, Scally CP, Mansfield P, Fournier KF, Uppal A, White M. Peritoneal Cancer Index Correlates with Radiographic Assessment in Colorectal Carcinomatosis. Society of Surgical Oncology Annual Meeting, 2024. PMID: None.
5. Ayabe RI, Melendez B, Chelvanambi M, Singh BB, Damania A, Fong L, Wong M, Hoballah Y, Lazar A, Lazcano R, Wani K, Alshenaifi JY, Taggart M, Ajami N, Kopetz S, You YN, Wargo J, White M. Spatial Profiling Reveals Modulation of the Rectal Adenocarcinoma Immune Microenvironment by Tumor-Associated Microbes. Society for Immunotherapy for Cancer Spring Symposium. Miami FL, 2024. PMID: None.
6. Ayabe R, Newhook T, Tran Cao H, Tzeng CWD, Scally CP, Helmink BA, Chun YS, Mansfield PF, Vauthey JN, White M. Incomplete Cytoreduction and Need for Major Hepatectomy Predict Shorter Survival in Patients Undergoing Combined Cytoreductive Surgery and Hepatectomy for Metastatic Colorectal Cancer. Society of Surgical Oncology Annual Meeting, 2024. PMID: None.
7. White M, Zeineddine MA, Fallon EA, eineddine FA, Dansby J, Chowdhury S, Hornstein N, Yousef A, Yousef M, Bhutiani N, Gu Y, Raghav K, Kopetz S, Uppal A, Helmink B, Taggart M, Newhook T, Fournier K, Drusbosky LM, Shen JP. The Landscape of Circulating Tumor DNA (ctDNA) in Appendiceal Adenocarcinoma (AA). Advanced Cancer Therapies, 2024. PMID: None.
8. Gunes BB, Hornstein N, Chowdhury S, Wang M, Yousef M, White M, Zeineddine M, Yousef A, Shen JP. Single Cell Transcriptomic Profiling of Appendiceal Adenocarcinoma Identifies Rare Tumors Cells and a Myeloid Enriched Tumor Microenvironment (TME). ASCO Gastrointestinal Cancers Symposium, 2024. PMID: None.
9. White M, Damania A, Alshenaifi J, Sahasrabhojane P, Peacock O, Losh J, Wong MC, Berkova Z, Nguyen S, Chang G, Wargo JA, Ajami N, Kopetz S, You YN. Tumoral Bacterial and Pathway Alterations Associated with Young-onset Rectal Cancer and its Response to Therapy. ASCO Gastrointestinal Cancers Symposium, 2024. PMID: None.
10. White M. Tumoral Bacterial and Pathway Alterations Associated with Young-onset Rectal Cancer and its Response to Therapy. MD Anderson & UT Austin Collaborative Research Summit, 2023. PMID: None.
11. Yousef A, Zeineddine M, Zeineddine F, Hornstein N, Beaty K, Foo WC, Taggert M, White M, Uppal A, Helmink B, Mansfield P, Scally C, Raghav K, Overman M, Fournier K, Shen JP. A Prospective Randomized Crossover Trial Demonstrates 5-FU-based Chemotherapy is Ineffective for Patients with Low-Grade Mucinous Appendiceal Adenocarcinoma. 13th PSOGI International Congress on Peritoneal Surface Malignancies, 2023. PMID: None.
12. Ivey S, Robinson K, Cox D, Helmink B, Scally C, Mansfield P, Fournier K, Uppal A, White M. Length of stay correlates with NGT and CT duration: persistently elevated outputs suggest caution in implementing enhanced recovery pathway after CRS and HIPEC. 13th PSOGI International Congress on Peritoneal Surface Malignancies, 2023. PMID: None.
13. Concors SJ, Beaty K, Bhutiani N, Song Y, Helmink B, Scally C, Mansfield P, Maxwell J, White M, Fournier K. Appendiceal Neoplasms Continue to Increase in Incidence – A Contemporary Population-Based Analysis. 13th PSOGI International Congress on Peritoneal Surface Malignancies, 2023. PMID: None.
14. Ito I, Yousef A, Dansby J, Chowdhury S, Haridas V, White M, Fowlkes N, Helmink B, Flatmark K, Fournier K, Shen JP. Orthotopic PDX & Organoid Models of Appendiceal Adenocarcinoma for the Discovery of Novel Active Drugs in this Orphan Disease. 13th PSOGI International Congress on Peritoneal Surface Malignancies, 2023. PMID: None.
15. Yousef A, Yousef MMG, Zeineddine M, More A, Chowdhury S, Knafl M, Edelkamp P, Ito I, Gu Y, Pattalachinti V, Naini ZA, Zeineddine F, Peterson J, Alfaro K, Foo WC, Jin J, Bhutiani N, Higbie V, Scally CP, Kee BK, Kopetz S, Goldstein D, Uppal A, White M, Helmink B, Fournier KF, Raghav K, Taggart M, Overman M, Shen JP. Quantitative serum tumor markers (CEA, CA19-9, and CA-125) are independently predictive of survival in patients with appendiceal adenocarcinoma. European Society of Medical Oncology Annual meeting, 2023. PMID: None.
16. White M, Helmink B, Rivero-Hinojosa S, Bhutiani N, Aushev VN, Chowdhury S, Jurdi A, Liu MC, Fournier KF, Shen JP. The genomic landscape of appendiceal adenocarcinoma revealed by 855 Whole Exome Sequences. 25th World Congress on Gastrointestinal Cancer, 2023. PMID: None.
17. Belmon E, Bansal V, Zeineddine A, White M, Polite B, Liao CY, Eng O, Turaga K, Shen JP, Shergill A. Multi-institutional study evaluating the role of circulating tumor DNA (ctDNA) in management of appendiceal cancers (AC). ASCO Annual Meeting Poster Presentation, 2023. PMID: None.
18. Konishi T, Bhutiani N, Messick C, Peacock O, Skibber J, Tillman M, Uppal A, White M, Bednarski B, You YN, Chang G. Robotic Redo Anterior Resection with Enblock D3 + Retroperitoneal Dissection for Recurrent Lymph Node Metastasis. Video Presentation. 2023 ASCRS, 2023. PMID: None.
19. Yousef A, McCormick A, Smith A, Ito I, Yousef M, Zeneddine MA, Helmink B, White M, Fournier K, Delubac D, Xiling S, Shen JP. Establishing functional models of peritoneal carcinomatosis using MicroOrganoSphere (MOS) technology. ASCO Annual Meeting Poster Presentation, 2023. PMID: None.
20. Yousef A, Yousef M, Zeineddine MA, Ito I, Chdhury S, Gu Y, Knafl M, Jin J, Edelkamp P, Uppal A, Bhutiani N, Alfaro-Munoz K, Bota-Rabassedas NN, Helmink B, White M, Taggart M, Raghav K, Overman M, Fournier K, Shen JP. Prognostic & predictive significance of pre- and post-operative plasma tumor markers in patients with appendiceal adenocarcinoma undergoing cytoreductive surgery: Insights from a single-center study. ASCO Annual Meeting Poster Presentation, 2023. PMID: None.
21. Manisundaram N, Hu CY, Uppal A, Peacock O, Bednarski B, Konishi K, White M, You N, Messick C, Tillman M, Skibber J, Das P, Smith G, Holliday E, Dasari A, Johnson B, Morris V, Chang G. Is there an increase in elective utilization of non-operative management for rectal cancer?. ASCO Annual Meeting Poster Presentation, 2023. PMID: None.
22. White M, Damania A, Alshenaifi JY, Sahasrabhojane P, Peacock O, Bednarski B, Losh J, Wong MC, Berkova Z, Nguyen S, Bhutiani N, Chang G, Wargo JA, Ajami N, Kopetz S, You YN. Young-Onset Rectal Cancer: Unique Tumoral Microbiome and Correlation with Response to Neoadjuvant Therapy. American Surgical Association Annual Meeting, 2023. PMID: None.
23. Bhutiani N, Concors S, White M, Helmink B, Rafeeq S, Scally C, Mansfield P, Fournier K. Repeat Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Appendiceal Adenocarcinoma: A Viable Treatment Strategy with Demonstrable Benefit. Oral Presentation. Podium Presentation. Advanced Cancer Therapeutics, 2023. PMID: None.
24. Bhutiani N, Concors S, Helmink B, Scally C, Zeineddine M, Yousef A, Raghav K, Mansfield P, Uppal A, Fournier K, Kopetz S, Shen JP, White M. Utility of circulating tumoral DNA in Appendiceal Tumors. Podium Presentation. Advanced Cancer Therapeutics 2023, 2023. PMID: None.
25. Ito I, Yousef AM, Dickson PN, Naini ZA, White M, Fournier KF, Fowlkes NW, Shen JP. Antitumor activity of intraperitoneal paclitaxel in orthotopic patient-derived xenograft models of mucinous appendiceal adenocarcinoma. Poster Presentation. Advanced Cancer Therapeutics 2023, 2023. PMID: None.
26. Bhutiani N, Concors S, Helmink B, Scally C, Zeineddine M, Yousef A, Raghav K, Mansfield P, Uppal A, Fournier K, Kopetz S, Shen JP, White M. Utility of circulating tumor DNA (ctDNA) in the management of appendiceal adenocarcinoma (AA). Poster Presentation. GI ASCO 2023, 2023. PMID: None.
27. Uppal A, White M, Chang GJ, Zeineddine FA, Zeineddine MA, Yousef AMG, Scally C, Fournier KF, Newhook TE, You N, Willis J, Kopetz S, Shen JP. Tumor mutations associated with outcomes in colorectal peritoneal metastases. GI ASCO 2023, 2023. PMID: None.
28. Janak A, Peacock O, White M, Guraieb-Trueba M, Nguyen S, Alshenaifi J, Kopetz S, Johnson B, Smith G, Chang G, You YN. Internet-based assessment tools for predicting colorectal cancer risk: How do they communicate individualized risk to the young adult? Poster Presentation. GI ASCO 2023, 2023. PMID: None.
29. Zeineddine MA, Zeineddine FA, Yousef A, Overman M, White M, Uppal A, Beaty K, Newhook T, Dasari A, Fournier K, Raghav K, Shen JP. Measurement of Circulating Tumor DNA in Appendiceal Adenocarcinoma (AA): Prevalence, Predictors, and Correlation with Clinical Outcome. ESMO, 2022. PMID: None.
30. Chapman L, White M, Willett A, Beaty K, Matamoros A, Taggart M, Foo WC, Scally C, Mansfield P, Malpica A, Raghav K, Fournier F. Neoadjuvant Chemotherapy (NACT) in Malignant Peritoneal Mesothelioma (MPeM) treated with Cytoreduction (CRS) and Heated Intraperitoneal Chemotherapy (HIPEC). Poster in Spotlight Presentation. ESSO 2022 Annual Meeting, 2022. PMID: None.
31. Nassif EF, Chelvanambi M, Chen L, Wu CC, Damania A, Keung EZ, Witt RG, White M, Ajami NJ, Wong MC, Somaiah N, Sepesi B, Basu S, Allison JP, Sharma P, McBride K, Fridman WH, Wargo JA, Cascone T, Roland CL. Identifying gut microbial signatures associated with B cells and tertiary lymphoid structures (TLS) in the tumor microenvironment (TME) in response to immune checkpoint blockade (ICB). Podium Presentation. ASCO 2022 Annual Meeting, 2022. PMID: None.
32. Zelazowska MA, Paul S, Plummer J, Chelvanambi M, Helmink B, Witt R, White M, Lotlikar S, Simper M, Johnson S, Hebertson A, Liu B, Wargo J, McBride KM. B-cell receptor (BCR) repertoire and antibody recognition analysis of melanoma patients treated with neoadjuvant immune checkpoint blockade (ICB). SITC 37th Annual Meeting. 2022, 2022. PMID: None.
33. White M Vellano CP, Andrews MC, Witt RG, Chelvanambi C, McQuade J, Burton EM, Chu Y, Lastrapes MJ, Lau M, Banerjee H, Lazar AJ, Davies MA, Woodman SE, Wang L, Moran A, Long G, Heffernan T, Marszalek J, Wargo JA. Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy. Poster Presentation. ASCO 2022 Annual Meeting, 2022. PMID: None.
34. White M, Cox D, Robinson K, Kim G, Bhutiani N, Shayeb O, Mansfield P, Royal R, Fournier F. Stapled Versus Hand-Sewn Intestinal Anastomosis in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy. Digestive Diseases Week. May 2022, 2022. PMID: None.
35. White M, Uppal A. Circulating Tumor DNA in Colorectal Carcinomatosis: Detection and Prognostic Value. Poster Presentation. AACR Special Conference on Colorectal Cancer 2022, 2022. PMID: None.
36. Chelvanambi M, Deboever N, Nassif E, Damania A, Chen L, Leung C, Keung E, Wu CC, Witt R, White M, Johnson S, Wong M, Mishra A, Lastrapes M, Somaiah N, Kadara H, Basu S, Allison JP, Sharma P, McBride KM, Fridman W, Heymach J, Sepesi B, Ajami N, Roland CL, Wargo JA, Cascone C. Metagenomic sequencing reveals unique gut microbial features associated with tertiary lymphoid structures in response to immune checkpoint blockade in solid cancers. SITC 37th Annual Meeting, 2022. PMID: None.
37. Ito I, White M, Yousef AM, Dickson PN, Gu Y, Fournier KF, Fowlkes NW, Shen JP. Orthotopic patient-derived xenograft models of appendiceal adenocarcinoma identify intraperitoneal paclitaxel treatment as an active therapeutic agent. American Association for Cancer Research Annual Meeting, 2021. PMID: None.
38. Li F, White M, Davis J, Hoffman KL, Menter D, Ajami N, Zhang X, Morris JS, Jenq RR, Petrosino J, Wargo JA, Kopetz S, Daniel CR. Tumor microbiota profiles are associated with molecular subtype and survival in colorectal cancer patients. American Association for Cancer Research Annual Meeting, 2021. PMID: None.
39. Newton AD, Newhook TE, Ikoma N, White MG, Tzeng CD, Chun YS, Aloia TA, Vauthey JN, Tran-Cao HS. Robotic Completion Radical Cholecystectomy with Fluorescence Guidance. Video Presentation. Society of Surgical Oncology International Conference on Surgical Cancer Care, 2021. PMID: None.
40. White MG, Tzeng CW, Ikoma N, Chun YS, Aloia TA, Vauthey JN, Tran Cao HS. Robotic Partial Segment VIII Resection. Video presentation. 14th World Congress of the International Hepato-Pancreatio-Biliary Association, 2020. PMID: None.
41. White M, Ikoma N, Murphy MB, Song S, Ajani J, Mansfield P, Badgwell B. Should Ascites be a Contraindication to Laparoscopic HIPEC in Gastric Cancer? Poster Presentation. Society of Surgical oncology International Conference on Surgical Cancer Care, 2020. PMID: None.
42. White M, Scally C. Low-Grade Appendiceal Mucinous Neoplasms: Treatment Variation and Long-Term Outcomes. Invited Presentation. 2020 South Texas American College of Surgeons Annual Meeting, 2020. PMID: None.
43. White M, Ikoma N, Murphy MB, Song S, Ajani J, Mansfield P, Badgwell B. Should Ascites be a Contraindication to Laparoscopic HIPEC in Gastric Cancer? Poster Presentation. Advanced Therapeutics Meeting, 2020. PMID: None.
44. Schuitevoerder D, Vining CC, White M, Hoppenot C, Lazo I, Sherman S, Kamm A, Chavez L, Kallakuri P, Fenton E, Male J, Tun S, Osmanuddin A, Semrad C, Radonanovic D, Eng O, Micic D, Lee NK, Polite BN, Turaga K. Impementation of an EMR Integrated Pathway in the Management of Malignant Bowel Obstruction. Poster Presentation. American Society of Clinical Oncology Gastroenterology, 2020. PMID: None.
45. Zhang L, Schuitevoerder D, White M, Feldt S, Krishnan P, Hyman N, Shogan B. Preoperative Combined Mechanical and Antibiotic Bowel Preparation Is Associated with Prolonged Recurrence-Free Survival in Patients Undergoing Operations for Colorectal Cancer. American College of Surgeons, 2019. PMID: None.
46. Plana A, White M, Schuitevoerder D, Turaga K, Lee N, Yamada D, Hoppenot C. Total parenteral nutrition in the setting of malignant bowel obstruction secondary to ovarian cancer: a retrospective matched-pairs survival analysis. Poster Presentation. Society for Surgical Oncology Annual Cancer Symposium, 2019. PMID: None.
47. Ruhle B, White M, Kaplan EL, Angelos P, Grogan RH. Unrecognized Primary Aldosteronism in Hypertensive Patients with Hypokalemia or Sleep Apnea. American Association of Endocrine Surgeons, 2018. PMID: None.
48. Plana A, Ferguson B, White M, Grant S, Angelos P, Kaplan E, Grogan R. Disparities in the Initiation of Adjuvant Breast Cancer Care at a Tertiary Academic Center. Poster Presentation. American College of Surgeons Clinical Congress, 2017. PMID: None.
49. White M, Applewhite MK, Kaplan EL, Angelos P, Grogan RH. Failing to Intervene on Thyroid Cancer: A Study of the National Cancer Database. Oral Presentation. American Association of Endocrine Surgeons, 2017. PMID: None.
50. White M, Applewhite MK, Anderson J, James BC, Benjamin A, Grant S, Plana A, Kaplan EL, Grogan RH. A Double Blind Randomized Control Trial Comparing Bilateral Superficial Cervical Plexus Block and Local Wound Infiltration in Total Thyroidectomy. Poster Presentation. American Association of Endocrine Surgeons, 2017. PMID: None.
51. Shakhsheer B, White M, Schindler N, Hussain M, Roggin K, Umanskiy K. Improving the ABSITE Score: Perfect Practice Makes Perfect. Poster Presentation. Association for Surgical Education, 2017. PMID: None.
52. Wong H, Kaplan S, White M, Angelos P, Kaplan EL, Grogan RH. Shoulder Disability is Common After Thyroid Resection Even Without Lymph Node Dissection: Results from the North American Thyroid Cancer Survivorship Study. Oral Presentation. Academic Surgical Congress, 2017. PMID: None.
53. White M, Applewhite MK, Kaplan EL, Angelos P, Huo D, Grogan RH. A Tale of Two Cancers: Traveling to Treat Pancreatic and Thyroid Cancer. Podium Presentation. Western Surgical Association Scientific Session, 2016. PMID: None.
54. Applewhite MD, White M, Mercier F, Kaplan EL, Aschebrook-Kilfoy B, Grogan RH, Angelos P. Informed Consent in Patients with Thyroid Cancer: One of The Keys to Improving Quality of Life. American College of Surgeons Clinical Congress, 2016. PMID: None.
55. Applewhite MK, White M, Mercier F, Kaplan E, Grogan R, Cipriani N, Angelos P. Practical Complexity and Ethical Challenges of the Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma. 86th Annual Meeting of the American Thyroid Association, 2016. PMID: None.

Book Chapters

1. Schokrpur S, White M, Roland CL, Patel SP. None. In: Immuno-Oncology: New Insights into Targets and Therapies. None. Elsevier, 2024.
2. White M, Wargo J, McQuade J. Microbiome and Cancer Metastasis. In: Cancer Metastasis and the Lymphovascular System: Basis for Rational Therapy. None. Springer, 2022.
3. White M, Wargo J. None. In: The Microbiome in Gastrointestinal Cancers. None. Elsevier, 2022.

Books (edited and written)

1. White M, DiBrito S, Kothari A, Gaskill C, Feig B. MD Anderson Surgical Oncology Handbook. Ed(s) 8E. Springer, 2023.

Letters to the Editor

1. Maddalena, G, Zeineddine, F, Rivero-Hinojosa, S, Aushev, VN, Chowdhury, S, Zeineddine, MA, Yousef, A, Yap, TA, EINaggar, AC, Liu, MC, White, MG, Overman, MJ, Kopetz, S, Shen, JY. Defining the subset of mutations in polymerase epsilon (POLE) associated with loss-of-proofreading (LOP) functionality. Annals of Oncology 35: 678-680, 2024.